Back to
Janus Henderson Group Ltd.
PYXSShowing 0 of 3 quarters
Position history for
Janus Henderson Group Ltd.'s holdings in PYXIS ONCOLOGY INC
No. Janus Henderson exited its PYXS (Pyxis Oncology) position in Q2 2022. Its Q1 2022 13F listed 1,396,967 shares worth $5.5M. Janus Henderson already held PYXS in its Q4 2021 13F, the earliest on record, and held it in 2 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of PYXS: RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP, CITADEL ADVISORS LLC, BALYASNY ASSET MANAGEMENT L.P., BlackRock, Inc.